Home - LIVER

Assoc. Prof. Cosmas Rinaldi A. Lesmana M.D., Ph.D., F.A.C.P, F.A.C.G, FINASIM

Welcome Message

Salam sehat,

Puji syukur kehadirat Tuhan Yang Maha Esa karena dengan rahmat dan karuniaNya kita masih dalam keadaan sehat. Dengan ini saya menyampaikan bahwa akan dilaksanakannya Acara Simposium dengan Tema “ New horizon and innovation in hepato pancreato billiary disorders ”. Acara tersebut akan berlangsung pada tanggal 21 – 22 Februari 2025.

Adapun target peserta Acara Simposium “Liver GI” ini adalah dokter spesialis penyakit dalam dan KGEH, serta dokter umum baik yang bertugas di puskesmas, klinik dan perusahaan. Acara Simposium ini dilaksanakan bertujuan untuk membahas inovasi baru dalam bidang hepato pancreato billiary tentang tata laksana penyakit hati, nutrisi, juga terkait pelaksanaan program-program Kemenkes khususnya subdit hepatitis. Selain itu juga akan mengupas tentang hepatobilier secara komprehensif. Dengan adanya Simposium ini diharapkan dapat memberikan wawasan baru terkait penyakit hati. Acara Simposium “Liver GI” ini terdiri dari berbagai topik diantaranya mengenai Hepatitis B, Hepatitis C, Perlemakan Hati, Kanker Hati, Sarkopenia, dan masih banyak lagi.

Semoga kita selalu dalam keadaan sehat dan lindungan Tuhan Yang Maha Esa, sehingga kita semua dapat menghadiri acara Simposium “Liver GI” di tanggal 21 & 22 Februari 2025

SCIENTIFIC EVENT

Main Event

Time : 21 & 22 February 2025
Location : SHANGRI - LA HOTEL, JAKARTA

Topics



Basic evaluation in MAFLD	• Liver enzyme test for early detection in population
	• Abdominal Ultrasound: Diagnosis, Monitoring, or Prediction?
	• Liver Elastography in primary health care
Connecting MAFLD with HCC	• The Role of Bile Acid in MAFLD
	• The Efficacy of TKI in HCC with MAFLD
	• Discussion
Liver Nodule	• Blood test and abdominal US evaluation: how to approach?	•••
	• Which imaging to choose: CT, MRI, or PET CT
	• Liver biopsy: to do or not to do?
Challenges in Managing Liver Disease	• Toward and Improve Management of Acute -on-Chronic Liver Failure (ACLF)
	• Current and Future Directions in the Treatment of DILI
	• Discussion
Believe and Be Relieved : Understanding Meteorism Unraveling the Diagnostic Aproach and Dietary Interventions to Pharmacotherapy	• Innovative Diagnostic Approaches in the Evaluation of Meteorismus
	• Management Strategies for Meteorism: From Dietary From Dietary Interventions to Pharmacotherapy
	• Discussion
Endo-Hepatology	• New concept of endoscopy in liver disease
	• Innovation of endoscopy evaluation in biliary disease
	• Variceal or Non-Variceal: How to Suspect in Emergency Room
Multidisciplinary Management in Liver Disease	• Liver resection in hepatobiliary malignancy
	• Cirrhosis in Anatomical Pathology Aspect
	• Radiotherapy in liver cancer
TBA	• Understanding MAFLD, It's Management and Emerging Role & Evidence of Antioxidants in Hepatic Detoxification
	• TBA
	• TBA
	• Discussion
Combination of Curcumin and Andrographolide as Hepatoprotector	• Liver injury in daily practice: Concept and Pathomechanism
	• Curcumin and Andrographolide in MAFLD
	• Discussion
Comprehensive Management of HCC Patients with Comorbidities: Integrating Immunotherapy for Optimized Outcomes	• Advances in Immunotheraphy for Hepatocellular Carcinoma
	• Atezolizumab + Bevacizumab Data in HCC Patients with Esophageal Varices
	• Discussion
	• Discussion
Liver Cirrhosis Complications	• H. Pylori Infection Management in Liver Cirrhosis
	• Ascites and Refractory Ascites
	• Hepatopulmonary Syndrome
	• Discussion
Clinical Approach of TAF, ARV and TACE in Management of HCC	• TBA
	•Effect of Tenovofir versus Entecavir on the Long-term Prognosis in MAFLD Patients
	• TBA
	• Discussion
Hot Topics	• Fatty Liver and Liver Cancer
	• Medication concept in obesity with fatty liver
	• Endoscopic treatment in fatty liver
	• Discussion